GGrantIndex
← Search

BOSENTAN VS PLACEBO IN NYHA CLASS I/II SCLERODERMA PATIENTS WITH EXERCISE INDUCE

$4,281M01FY2008RRNIH

Georgetown University, Washington DC

Investigators

Linked publications & trials

View original record on NIH RePORTER →